Physician profile
Jonathan C Commander
NPI 1992894083
$1,589.79
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $460 · 2021: $343 · 2022: $285 · 2023: $207 · 2024: $16.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $312.45 | 2019-2023 | Mounjaro |
| Novo Nordisk INC | $165.79 | 2019-2023 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.57 | 2020-2022 | |
| Glaxosmithkline, LLC. | $127.08 | 2021-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $112.37 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $103.97 | 2020-2021 | |
| Abbvie INC. | $102.52 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $62.74 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $47.69 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $45.46 | 2019-2022 | |
| Allergan, INC. | $44.91 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $42.52 | 2021-2022 | |
| Amarin Pharma, INC. | $38.38 | 2019 | |
| Xeris Pharmaceuticals, INC. | $38.28 | 2023 | Gvoke Hypopen |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33.98 | 2021-2023 | Freestyle Libre 3 |
| Astellas Pharma US INC | $29.48 | 2019 | |
| Braemar Manufacturing, LLC | $22.10 | 2019 | |
| Lundbeck LLC | $21.06 | 2023 | Rexulti |
| Mylan Specialty L.P. | $16.57 | 2024 | Yupelri |
| Hikma Pharmaceuticals USA | $16.20 | 2019 | |
| Philips North America LLC | $13.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Commander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.